Silo pharma advances ptsd drug spc-15 toward planned 2025 ind submission with pre-clinical study data expected in q3 2025

Planned submission of ind application in 2025; phase 1 clinical trial to follow if ind application approved

SILO Ratings Summary

SILO Quant Ranking